| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-06 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |
| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.22 |
0.0004 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |